➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Mallinckrodt
Medtronic
McKesson
Baxter

Last Updated: May 28, 2020

DrugPatentWatch Database Preview

ALECTINIB HYDROCHLORIDE - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for alectinib hydrochloride and what is the scope of patent protection?

Alectinib hydrochloride is the generic ingredient in one branded drug marketed by Hoffmann-la Roche and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Alectinib hydrochloride has one hundred and seven patent family members in thirty-eight countries.

One supplier is listed for this compound.

Summary for ALECTINIB HYDROCHLORIDE
International Patents:107
US Patents:4
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 32
Clinical Trials: 30
Patent Applications: 8
DailyMed Link:ALECTINIB HYDROCHLORIDE at DailyMed
Recent Clinical Trials for ALECTINIB HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
GlaxoSmithKlinePhase 2
PfizerPhase 2
Ulrik LassenPhase 2

See all ALECTINIB HYDROCHLORIDE clinical trials

Pharmacology for ALECTINIB HYDROCHLORIDE
Drug ClassKinase Inhibitor
Mechanism of ActionKinase Inhibitors
Synonyms for ALECTINIB HYDROCHLORIDE
1256589-74-8
3341AH
5H-Benzo[B]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-ipperidinyl]-11-oxo-, hydrochloride (1:1)
5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-, hydrochloride (1:1)
9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile hydrochloride (1:1)
9-ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile monohydrochloride salt
9-Ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[B]carbazole-3-carbonitrile,hydrochloride
9-ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile hydrochloride
AC-29721
ACN-050755
AF-802 hydrochloride
AK174941
Alecensa
Alecensa (TN)
Alectinib (Hydrochloride)
Alectinib hydrochloride (JAN)
Alectinib Hydrochloride;AF-802 Hydrochloride;CH-5424802 Hydrochloride;RG-7853 Hydrochloride;RO-5424802 Hydrochloride
alectinib monohydrochloride
AOB87772
AS-17062
BCP09075
C30H34N4O2.ClH
CH5424802 (Hydrochloride)
CH5424802 HCl
CH5424802 HCl salt, Alectinib HCl salt, AF802 HCl salt
CH5424802(Hydrochloride)
CHEBI:62268
CHEMBL3707320
CS-3480
D10450
DTXSID10154841
EX-A1553
GYABBVHSRIHYJR-UHFFFAOYSA-N
HY-13011A
KS-00001D3B
P9YY73LO6J
Q27104897
s5232
SB16516
SCHEMBL14991271
UNII-P9YY73LO6J
Paragraph IV (Patent) Challenges for ALECTINIB HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
ALECENSA CAPSULE;ORAL alectinib hydrochloride 208434 2019-12-11

US Patents and Regulatory Information for ALECTINIB HYDROCHLORIDE